Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OrganoClick AB (FRA:0CF) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
OrganoClick AB Forward PE Ratio Related Terms
OrganoClick AB Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for OrganoClick AB's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OrganoClick AB Forward PE Ratio Chart
OrganoClick AB Annual Data
Trend
Forward PE Ratio
OrganoClick AB Quarterly Data
Forward PE Ratio
FRA:0CF vs LIN, SHW, ECL: Forward PE Ratio Comparison
For the Specialty Chemicals subindustry, OrganoClick AB's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OrganoClick AB Forward PE Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, OrganoClick AB's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where OrganoClick AB's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
OrganoClick AB (FRA:0CF) has a Forward PE Ratio of 114.00 as of Jul. 17, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on OrganoClick AB and its competitors. According to the industry distribution chart, OrganoClick AB ranks #635 out of 660 companies in the Chemicals industry, placing it in the top 96.2%.
Is OrganoClick AB's Forward PE Ratio too high?
OrganoClick AB's current Forward PE Ratio is 114.00. The Chemicals industry median Forward PE Ratio is 18.34. OrganoClick AB's value of 114.00 is 521.6% above this industry median. Based on the distribution chart, OrganoClick AB ranks #635 out of 660 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, OrganoClick AB has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does OrganoClick AB's Forward PE Ratio compare to LIN and SHW?
According to the Chemicals industry distribution chart, OrganoClick AB ranks #635 out of 660 companies for Forward PE Ratio. This places OrganoClick AB in the lower half of its industry. The industry median Forward PE Ratio is 18.34. OrganoClick AB's value of 114.00 is 521.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Chemicals company?
The median Forward PE Ratio among Chemicals companies is 18.34, based on 660 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OrganoClick AB's current Forward PE Ratio of 114.00 is 521.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on OrganoClick AB and its competitors. For the Chemicals industry, the median Forward PE Ratio is 18.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OrganoClick AB's current Forward PE Ratio is 114.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OrganoClick AB stock overvalued right now?
OrganoClick AB (FRA:0CF) has a current Forward PE Ratio of 114.00. The stock's GF Value™ is €0.14, compared to a current price of €0.02 — trading 82.7% below its estimated fair value. The current Forward PE Ratio is 114.00 and 521.6% above the Chemicals industry median of 18.34. OrganoClick AB's overall GF Score™ is 25/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For OrganoClick AB (FRA:0CF), the current Forward PE Ratio is 114.00 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OrganoClick AB (FRA:0CF) Overvalued in 2026?
Based on GuruFocus' analysis, OrganoClick AB stock appears to be undervalued.
The current stock price of €0.02 is trading 82.7% below its estimated GF Value™ of €0.14.
Key valuation signals for FRA:0CF:
Forward PE Ratio: 114.00
GF Value™: €0.14 vs. price of €0.02 (82.7% below fair value)
Industry Position: 521.6% above the Chemicals median (#635 of 660)
No single metric tells the full story. See the FRA:0CF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OrganoClick AB is involved in the chemicals industry. Its product portfolio includes green chemical technologies for creating water repellency, biobased binders for increasing the mechanical strength, and wood treatment products for resistance to fungal degradation and resistance to fire. It operates in four business areas Functional Wood, Green coatings & maintenance products, Nonwoven & technical textile, and Other. The group has a single operating segment.
25GF Score
Get the complete analysis for FRA:0CF
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:0CF has been successfully added to your 
